EINSTEIN–Pulmonary Embolism (PE) Study - EINSTEIN–PE

Description:

The goal of the trial was to evaluate treatment of the oral direct factor Xa inhibitor, rivaroxaban, compared with standard therapy among patients with symptomatic pulmonary embolism (PE).